Pharmacokinetic aspects of the clinically used proteasome inhibitor drugs and efforts toward nanoparticulate delivery systems Review

Kwon, Seungbin, Kim, Kyung Bo, Yeo, Yoon et al. (2021). Pharmacokinetic aspects of the clinically used proteasome inhibitor drugs and efforts toward nanoparticulate delivery systems . Journal of Pharmaceutical Investigation, 51(4), 483-502. 10.1007/s40005-021-00532-0

International Collaboration

cited authors

  • Kwon, Seungbin; Kim, Kyung Bo; Yeo, Yoon; Lee, Wooin

sustainable development goals

authors

publication date

  • July 1, 2021

published in

keywords

  • ADVANCED SOLID TUMORS
  • ANTITUMOR-ACTIVITY
  • BORTEZOMIB
  • Bortezomib
  • CANCER
  • CARFILZOMIB
  • Carfilzomib
  • EFFICACY
  • IXAZOMIB
  • Life Sciences & Biomedicine
  • Nanoparticulate drug delivery
  • OPEN-LABEL
  • Pharmacokinetics
  • Pharmacology & Pharmacy
  • Proteasome inhibitors
  • RELAPSED MULTIPLE-MYELOMA
  • SINGLE-ARM
  • Science & Technology

Digital Object Identifier (DOI)

start page

  • 483

end page

  • 502

volume

  • 51

issue

  • 4